{"id":"https://openalex.org/W2188777076","doi":null,"title":"Ranibizumab in Circulatory Disorder of Retinal Vein: an Evidence-based Approach","display_name":"Ranibizumab in Circulatory Disorder of Retinal Vein: an Evidence-based Approach","publication_year":2012,"publication_date":"2012-01-01","ids":{"openalex":"https://openalex.org/W2188777076","mag":"2188777076"},"language":"en","primary_location":{"id":"mag:2188777076","doi":null,"is_oa":false,"landing_page_url":"http://www.bepls.com/dec_2012/10.pdf","pdf_url":null,"source":null,"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":null},"volume":null,"type":"article","is_traditional":true,"indexed_in":[],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5058472912","display_name":"Marianne Levon Shahsuvaryan","orcid":"https://orcid.org/0000-0003-3627-4137","observed_orcids":["https://orcid.org/0000-0003-3627-4137"]},"institutions":[],"countries":[],"is_corresponding":true,"raw_author_name":"Marianne L. Shahsuvaryan","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":["https://openalex.org/A5058472912"],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":0.0,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":{"value":0.0,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":null,"issue":null,"first_page":null,"last_page":null},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10170","display_name":"Retinal Diseases and Treatments","score":0.9961000084877014,"subfield":{"id":"https://openalex.org/subfields/2731","display_name":"Ophthalmology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10170","display_name":"Retinal Diseases and Treatments","score":0.9961000084877014,"subfield":{"id":"https://openalex.org/subfields/2731","display_name":"Ophthalmology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11377","display_name":"Retinal and Macular Surgery","score":0.0007999999797903001,"subfield":{"id":"https://openalex.org/subfields/2731","display_name":"Ophthalmology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11194","display_name":"Ocular Diseases and Beh\u00e7et\u2019s Syndrome","score":0.000699999975040555,"subfield":{"id":"https://openalex.org/subfields/2731","display_name":"Ophthalmology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/ranibizumab","display_name":"ranibizumab","score":1.0},{"id":"https://openalex.org/keywords/retinal-vein-occlusion","display_name":"retinal vein occlusion","score":0.925000011920929},{"id":"https://openalex.org/keywords/central-retinal-vein-occlusion","display_name":"central retinal vein occlusion","score":0.9269999861717224},{"id":"https://openalex.org/keywords/branch-retinal-vein-occlusion","display_name":"branch retinal vein occlusion","score":1.0},{"id":"https://openalex.org/keywords/anti-vegf-therapy","display_name":"anti-VEGF therapy","score":0.9860000014305115},{"id":"https://openalex.org/keywords/vascular-endothelial-growth-factor","display_name":"vascular endothelial growth factor","score":0.8939999938011169},{"id":"https://openalex.org/keywords/macular-edema","display_name":"macular edema","score":0.9150000214576721},{"id":"https://openalex.org/keywords/treatment-timing","display_name":"treatment timing","score":0.7020000219345093},{"id":"https://openalex.org/keywords/retreatment","display_name":"retreatment","score":0.7670000195503235},{"id":"https://openalex.org/keywords/visual-outcome","display_name":"visual outcome","score":0.6779999732971191},{"id":"https://openalex.org/keywords/drug-safety","display_name":"drug safety","score":0.41100001335144043}],"concepts":[{"id":"https://openalex.org/C2781100027","wikidata":"https://www.wikidata.org/wiki/Q414270","display_name":"Ranibizumab","level":4,"score":0.9730491638183594},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.8002558946609497},{"id":"https://openalex.org/C2780261187","wikidata":"https://www.wikidata.org/wiki/Q4956400","display_name":"Branch retinal vein occlusion","level":4,"score":0.690447986125946},{"id":"https://openalex.org/C2908732032","wikidata":"https://www.wikidata.org/wiki/Q5062148","display_name":"Retinal Vein","level":3,"score":0.6834260821342468},{"id":"https://openalex.org/C2910227669","wikidata":"https://www.wikidata.org/wiki/Q169342","display_name":"Retinal Disorder","level":3,"score":0.5995377898216248},{"id":"https://openalex.org/C2778844676","wikidata":"https://www.wikidata.org/wiki/Q190831","display_name":"Central retinal vein occlusion","level":4,"score":0.5974113345146179},{"id":"https://openalex.org/C118487528","wikidata":"https://www.wikidata.org/wiki/Q161437","display_name":"Ophthalmology","level":1,"score":0.5573682188987732},{"id":"https://openalex.org/C2780347916","wikidata":"https://www.wikidata.org/wiki/Q1813737","display_name":"Macular edema","level":3,"score":0.4930700957775116},{"id":"https://openalex.org/C2780827179","wikidata":"https://www.wikidata.org/wiki/Q422001","display_name":"Retinal","level":2,"score":0.4412819445133209},{"id":"https://openalex.org/C2777202286","wikidata":"https://www.wikidata.org/wiki/Q9609","display_name":"Vein","level":2,"score":0.4235846996307373},{"id":"https://openalex.org/C2776268601","wikidata":"https://www.wikidata.org/wiki/Q968808","display_name":"Occlusion","level":2,"score":0.4200628399848938},{"id":"https://openalex.org/C141071460","wikidata":"https://www.wikidata.org/wiki/Q40821","display_name":"Surgery","level":1,"score":0.3159838914871216},{"id":"https://openalex.org/C2777802072","wikidata":"https://www.wikidata.org/wiki/Q413299","display_name":"Bevacizumab","level":3,"score":0.2876300513744354},{"id":"https://openalex.org/C2776694085","wikidata":"https://www.wikidata.org/wiki/Q974135","display_name":"Chemotherapy","level":2,"score":0.10766372084617615}],"mesh":[],"locations_count":1,"locations":[{"id":"mag:2188777076","doi":null,"is_oa":false,"landing_page_url":"http://www.bepls.com/dec_2012/10.pdf","pdf_url":null,"source":null,"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":null}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":0.9789000153541565}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":45,"referenced_works":["https://openalex.org/W1494416455","https://openalex.org/W1501964064","https://openalex.org/W1543694381","https://openalex.org/W1731074416","https://openalex.org/W1968756919","https://openalex.org/W1971635267","https://openalex.org/W1972242350","https://openalex.org/W1973704949","https://openalex.org/W1973829948","https://openalex.org/W1975265153","https://openalex.org/W1977995451","https://openalex.org/W1998525239","https://openalex.org/W2002196338","https://openalex.org/W2004460690","https://openalex.org/W2015655380","https://openalex.org/W2018352429","https://openalex.org/W2021372623","https://openalex.org/W2031329755","https://openalex.org/W2038818854","https://openalex.org/W2039446733","https://openalex.org/W2040983439","https://openalex.org/W2045247659","https://openalex.org/W2051103210","https://openalex.org/W2052204551","https://openalex.org/W2053255808","https://openalex.org/W2054551550","https://openalex.org/W2059265707","https://openalex.org/W2063074271","https://openalex.org/W2077317818","https://openalex.org/W2079693408","https://openalex.org/W2088346043","https://openalex.org/W2098369792","https://openalex.org/W2099842384","https://openalex.org/W2102012604","https://openalex.org/W2108237040","https://openalex.org/W2121220148","https://openalex.org/W2128701654","https://openalex.org/W2141923736","https://openalex.org/W2144771657","https://openalex.org/W2154763327","https://openalex.org/W2177233106","https://openalex.org/W2238184109","https://openalex.org/W2290388520","https://openalex.org/W2317364432","https://openalex.org/W2403930213"],"related_works":["https://openalex.org/W2160528544","https://openalex.org/W2129223002","https://openalex.org/W7100319023","https://openalex.org/W2146203027","https://openalex.org/W2018840029","https://openalex.org/W2328781807","https://openalex.org/W2074654625","https://openalex.org/W2258174981","https://openalex.org/W1994687820","https://openalex.org/W3010879414"],"abstract_inverted_index":{"The":[0,67,108],"discovery":[1],"of":[2,22,39,50,69,95,99,117,128,153,197,222],"anti-angiogenics":[3],"or":[4],"vascular":[5],"endothelial":[6],"growth":[7],"factor":[8],"inhibitors":[9],"(anti-VEGF)":[10],"agents":[11],"is":[12,25,72,145,161,204],"a":[13,26,103],"clear":[14],"breakthrough":[15],"with":[16,119,156,216],"exciting":[17],"potential":[18],"in":[19,92,138],"medical":[20],"management":[21],"retinal":[23,57,63,100,104,224],"diseases.Ranibizumab":[24],"humanized,":[27],"affinitymatured":[28],"VEGF":[29],"antibody":[30],"fragment":[31],"that":[32,85,112,207],"binds":[33],"to":[34,54,73,141,163,171,183],"and":[35,61,77,130,135,158,176,189,195],"neutralizes":[36],"all":[37],"isoforms":[38],"VEGF,":[40],"which":[41],"has":[42,181],"first":[43],"received":[44],"FDA":[45],"approval":[46],"for":[47],"the":[48,75,79,82,93,120,125,139,150,174,193,211,223],"treatment":[49,94,116,155],"macular":[51],"edema":[52],"due":[53],"both":[55,132],"central":[56],"vein":[58,64,101,105],"occlusion":[59,65,106],"(CRVO)":[60],"branch":[62],"(BRVO).":[66],"objective":[68],"this":[70],"review":[71],"evaluate":[74],"evidence":[76,110],"discuss":[78],"rationale":[80],"behind":[81],"recent":[83],"suggestions":[84],"pharmacotherapy":[86],"by":[87],"Ranibizumab":[88],"may":[89],"be":[90,164,172,184],"useful":[91],"such":[96],"circulatory":[97,220],"disorder":[98,221],"as":[102],"(RVO).":[107],"available":[109,199],"suggests":[111],"repeated":[113],"early":[114],"frequent":[115],"RVO":[118],"anti-VEGF":[121],"agent":[122],"ranibizumab,":[123],"gives":[124],"best":[126,212],"chance":[127],"achieving":[129],"stabilizing":[131],"optimal":[133,151],"anatomical":[134],"visual":[136],"outcomes":[137],"short":[140],"medium":[142],"term.":[143],"There":[144],"no":[146],"standard":[147],"protocol":[148,213],"regarding":[149],"timing":[152],"initial":[154],"ranibizumab":[157,201],"subsequent":[159],"retreatment":[160],"yet":[162,182],"formulated.":[165],"Where":[166],"multiple":[167],"injections":[168],"are":[169],"likely":[170,206],"required,":[173],"effectiveness":[175],"safety":[177,196],"over":[178],"longer":[179],"periods":[180],"determined.":[185],"With":[186],"more":[187],"research":[188],"experience":[190],"into":[191],"exploring":[192],"frequency":[194],"currently":[198],"agent-":[200],",":[202],"it":[203],"also":[205],"clinicians":[208],"would":[209],"achieve":[210],"when":[214],"dealing":[215],"patients":[217],"sufferring":[218],"from":[219],"vein.":[225]},"counts_by_year":[],"updated_date":"2026-09-22T06:50:58.402377","created_date":"2016-06-24T00:00:00"}